The cost-effectiveness of celecoxib and rofecoxib in patients with osteoarthritis or rheumatoid arthritis / Andreas Maetzel, Murray Krahn, Gary Naglie

The cost-effectiveness of celecoxib and rofec ...
Maetzel, Andreas., Krahn, Murr ...
Locate

My Reading Lists:

Create a new list

Check-In

×Close
Add an optional check-in date. Check-in dates are used to track yearly reading goals.
Today


Buy this book

Last edited by WorkBot
January 29, 2010 | History

The cost-effectiveness of celecoxib and rofecoxib in patients with osteoarthritis or rheumatoid arthritis / Andreas Maetzel, Murray Krahn, Gary Naglie

This edition doesn't have a description yet. Can you add one?

Buy this book

Edition Availability
Cover of: The cost-effectiveness of celecoxib and rofecoxib in patients with osteoarthritis or rheumatoid arthritis / Andreas Maetzel, Murray Krahn, Gary Naglie
The cost-effectiveness of celecoxib and rofecoxib in patients with osteoarthritis or rheumatoid arthritis / Andreas Maetzel, Murray Krahn, Gary Naglie
Publish date unknown, Canadian Coordinating Office for Health Technology Assessment
in English
Cover of: The cost-effectiveness of Celecoxib and Rofecoxib in patients with osteoarthritis or rheumatoid arthritis
The cost-effectiveness of Celecoxib and Rofecoxib in patients with osteoarthritis or rheumatoid arthritis
Publish date unknown, Canadian Coordinating Office for Health Technology Assessment

Add another edition?

Book Details


Edition Notes

27

Published in
Ottawa
Series
Technology report ( Canadian Coordinating Office for Health Technology Assessment) ; issue 23

The Physical Object

Pagination
vii, 39 p.
Number of pages
39

ID Numbers

Open Library
OL21979273M
ISBN 10
1894620356
OCLC/WorldCat
50003070

Community Reviews (0)

Feedback?
No community reviews have been submitted for this work.

Lists

This work does not appear on any lists.

History

Download catalog record: RDF / JSON
January 29, 2010 Edited by WorkBot add more information to works
December 11, 2009 Created by WorkBot add works page